B-Cell Epitope Mapping of the Vibrio cholera Toxins A, B, and P and an ELISA Assay

• Published in: International journal of molecular sciences 2022-12, Vol.24 (1), p.531
• Main Authors: De-Simone, Salvatore G, Napoleão-Pêgo, Paloma, Gonçalves, Priscilla S, Lechuga, Guilherme C, Cardoso, Sergian V, Provance, Jr, David W, Morel, Carlos M, da Silva, Flavio R
• Format: Article
• Language: English
• Subjects: B-cell epitope; cholera toxin; ELISA; peptide microarray; synthetic peptide
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24010531

Oral immunization with the choleric toxin (CT) elicits a high level of protection against its enterotoxin activities and can control cholera in endemic settings. However, the complete B-cell epitope map of the CT that is responsible for protection remains to be clarified. A library of one-hundred, twenty-two 15-mer peptides covering the entire sequence of the three chains of the CT protein (CTP) was prepared by SPOT synthesis. The immunoreactivity of membrane-bound peptides with sera from mice vaccinated with an oral inactivated vaccine (Schankol™) allowed the mapping of continuous B-cell epitopes, topological studies, multi-antigen peptide (MAP) synthesis, and Enzyme-Linked Immunosorbent Assay (ELISA) development. Eighteen IgG epitopes were identified; eight in the CTA, three in the CTB, and seven in the protein P. Three specific epitopes, Vc/TxA-3, Vc/TxB-11, and Vc/TxP-16, were synthesized as MAP4 and used to coat ELISA plates in order to screen immunized mouse sera. Sensitivities and specificities of 100% were obtained with the MAP4s of Vc/TxA-3 and Vc/TxB-11. The results revealed a set of peptides whose immunoreactivity reflects the immune response to vaccination. The array of peptide data can be applied to develop improved serological tests in order to detect cholera toxin exposure, as well as next generation vaccines to induce more specific antibodies against the cholera toxin.